Effects of Exercise Timing on Sleep Quality (SLEEPCORE)

Effects of Exercise Timing and Physical Activity Level on Sleep Quality and Body Temperature

Modern lifestyles are marked by a prevalence of sedentary behaviors and physical inactivity, which have been linked to numerous adverse health effects. While regular physical exercise is a well-established countermeasure, exercising in the late afternoon may paradoxically disrupt deep sleep due to increased core body temperature. Inactive and sedentary individuals, who often have impaired autonomic function compared to endurance-trained athletes, may be particularly susceptible to these negative effects, potentially resulting in compromised thermoregulation and exacerbated disruptions to deep sleep, a critical stage of sleep essential for overall recovery. Therefore, this study aims to investigate the impact of aerobic exercise performed in the late afternoon versus morning on: 1) deep sleep and sleep onset latency; and 2) core body temperature and its autonomic regulatory mechanisms on endurance-trained and inactive-sedentary people.

Study Overview

Status

Recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

42

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Saint-Etienne, France, 42055
        • Recruiting
        • CHU Saint-Etienne
        • Sub-Investigator:
          • David HUPIN, MD
        • Sub-Investigator:
          • Léonard FEASSON, PhD
        • Sub-Investigator:
          • Clément FOSCHIA, MD
        • Sub-Investigator:
          • Philippe BOIRON, MD
        • Contact:
        • Contact:
        • Principal Investigator:
          • Frédéric ROCHE, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Group "Inactive" :No regular exercise practice (inactive people that don't follow the WHO recommendations) and have sedentary behaviors
  • Group "Active": Regular exercise (athletes that are specialized in aerobic exercise, with more than 300 minutes per-week over 6 months and practice at regional level).

Exclusion Criteria:

  • Have sleep disorders medically diagnosed or detected by sleep forms cutoffs (clinical insomnia by ISI, severe risk of obstructive sleep apnea by Stop-Bang, bad sleep quality by PSQI.
  • Have a diagnosed mental health condition requiring treatment
  • Have renal, respiratory, cardiovascular or neuromuscular disease medically diagnosed.
  • Be pregnant or breastfeeding

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: "Inactive-sedentary" group
inactive participants that realize 3 experimental conditions: evening exercise, morning exercise and control (no-exercise).
The exercise consists of running on a treadmill at 90% of maximum aerobic speed (MAS) for 30 minutes, followed by 12% increments every 5 minutes, until exhaustion (a "time-to-exhaustion" type of exercise).
Experimental: "Active" group
endurance athletes that realize 3 experimental conditions: evening exercise, morning exercise and control (no-exercise).
The exercise consists of running on a treadmill at 90% of maximum aerobic speed (MAS) for 30 minutes, followed by 12% increments every 5 minutes, until exhaustion (a "time-to-exhaustion" type of exercise).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Duration of deep slow-wave sleep
Time Frame: Once a month for 3 months
Evaluation of the duration of deep slow-wave sleep (N3 stage) quantified by the EEG signal from polysomnography (Nox A1, Resmed®, USA).
Once a month for 3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessment of core temperature
Time Frame: Once a month for 3 months
Assessment of core temperature until the end of the sleep period will be measured using gastrointestinal telemetric pills (eCelsius, Bodycap®, France).
Once a month for 3 months
Evaluation of autonomic nervous system thermoregulation
Time Frame: Once a month for 3 months
Evaluation of autonomic nervous system thermoregulation through time-domain (R-R intervals in ms)
Once a month for 3 months
Evaluation of autonomic nervous system thermoregulation
Time Frame: Once a month for 3 months
Evaluation of autonomic nervous system thermoregulation through frequency- domain parameters (in Hz)
Once a month for 3 months
Complementary sleep evaluation
Time Frame: Once a month for 3 months
Complementary sleep evaluation through analysis of duration of N1, N2, and REM stages (in Percentage of Total Sleep Time)
Once a month for 3 months
Complementary sleep evaluation
Time Frame: Once a month for 3 months
Complementary sleep evaluation through characteristics of slow waves present in N3 (amplitude in microvolts)
Once a month for 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Frédéric ROCHE, PhD, Centre Hospitalier Universitaire de Saint Etienne

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 23, 2026

Primary Completion (Estimated)

January 31, 2029

Study Completion (Estimated)

May 31, 2029

Study Registration Dates

First Submitted

November 21, 2025

First Submitted That Met QC Criteria

December 22, 2025

First Posted (Actual)

January 7, 2026

Study Record Updates

Last Update Posted (Actual)

June 3, 2026

Last Update Submitted That Met QC Criteria

June 1, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

This study is realized only in St-Etienne university Hospital

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Endurance Athlet

Clinical Trials on Aerobic Exercise

Subscribe